Tools
Auto-Brewery Syndrome
Introduction
Auto-brewery syndrome, or gut fermentation syndrome, is a condition in which ethanol is produced through endogenous fermentation by bacteria or fungi, most commonly in the gastrointestinal system, but also reported in the oral cavity or urinary system.[1][2] Patients with auto-brewery syndrome present with signs and symptoms of alcohol intoxication in the absence of alcohol ingestion. Affected patients often report an ultra-refined, high-sugar, high-carbohydrate diet.[3] The bouts of unexpected intoxication have profound physical, psychological, legal, and social ramifications in patients’ lives.[3]
The generation of endogenous ethanol occurs in minute quantities as part of normal digestion.[2] In patients with predisposing factors that perturb the microbial ecosystem of the gastrointestinal tract, an overgrowth of these fermenting bacteria, and rarely yeast, leads to the fermentation of dietary carbohydrates into ethanol. Auto-brewery syndrome occurs when the quantities exceed the liver's capacity for first-pass metabolism. Serum ethanol levels can range from minimally to extremely elevated.[4]
Auto-brewery syndrome remains a rare condition, and current knowledge largely derives from case reports and case series.[2] Reported risk factors include antibiotic exposure, intestinal stasis, and high carbohydrate intake.[2] Reported comorbidities include short bowel syndrome, Crohn disease, and diabetes mellitus; however, cases have also been documented in individuals with no apparent underlying health conditions.[5] Although diagnoses remain uncommon, available evidence suggests that auto-brewery syndrome is likely underrecognized and underdiagnosed in clinical practice.[6]
Etiology
Register For Free And Read The Full Article
Search engine and full access to all medical articles- 10 free questions in your specialty
- Free CME/CE Activities
- Free daily question in your email
- Save favorite articles to your dashboard
- Emails offering discounts
Learn more about a Subscription to StatPearls Point-of-Care
Etiology
Ethanol is a by-product of intestinal fermentation in nearly all people, which is typically negligible. In patients with auto-brewery syndrome, blood alcohol levels can range from mild intoxication to life-threatening levels. When the liver’s capacity to metabolize products of fermentation is overwhelmed, the result is auto-brewery syndrome.[2] An overabundance of fermenting microbes causes auto-brewery syndrome.[1]
The triggers for the characteristic dysbiotic state of auto-brewery syndrome include factors that disrupt normal microbial homeostasis.[7] These triggers encompass several contributing factors, ranging from medications to comorbid conditions.
Antibiotics and Other Medications
Antibiotics are well established as one of the most profound and long-lasting insults to the gut microbiota. Even a single course of antibiotics can lead to changes detectable up to 8 years later.[8][9][10] A systematic review of case reports found that antibiotics may trigger auto-brewery syndrome.[5]
Numerous medication classes have been identified as risk factors for small intestinal microbial dysbiosis through various mechanisms, including suppression of gastric acid secretion or inhibition of gastrointestinal motility. These include proton pump inhibitors, opioids, and glucagon-like peptide-1 receptor agonists.[10][11] Moreover, acid suppression has been shown to enhance endogenous ethanol production in the stomach.[2][11] While little is known about specific medications and auto-brewery syndrome, a case-control study found a significantly higher rate of acne medications, particularly antibiotics, among individuals with auto-brewery syndrome.[12]
Dietary and Malnutritional Factors
A high-carbohydrate diet, particularly simple sugars, preferentially shifts microbial composition toward a fermenting, ethanol-generating enterotype.[2] In patients with metabolic dysfunction-associated steatotic liver disease (MASLD), a mixed-meal test significantly increases blood alcohol, and this is associated with an abundance of Lactobacillaceae.[13] Hexoses (glucose and fructose) produce the highest ethanol levels (compared with pentoses and disaccharides), particularly when metabolized by Saccharomyces cerevisiae, Lactobacillus fermentum, and Weissella confusa.[14] In patients with auto-brewery syndrome, monosaccharides have been shown to induce ethanol production by specific bacterial species, including Klebsiella.[7][15]
A case of auto-brewery syndrome was reported postmortem in a severely malnourished child in association with candidal gastric ulcers.[16] Poor nutrition increases the risk of auto-brewery syndrome, whether due to a lack of nutrients that balance and diversify the gut microbiome or to an excess of carbohydrates that promote fermenting organisms.
Alcohol Use
Alcohol use disrupts the gut microbiome and may lead to or exacerbate auto-brewery syndrome.[17][18] While alcohol is not a sugar, sugar and alcohol are metabolized in the body in similar ways. Fructose and ethanol follow the same biochemical pathways, damage mitochondria, drive insulin resistance, and contribute to fatty liver and type 2 diabetes.[19] Long-term exposure to externally or internally produced ethanol can lead to cravings for and alcohol addiction, potentially resulting in a secondary alcohol use disorder.[3]
Short Bowel Syndrome
Short bowel syndrome is strongly associated with small intestinal microbial dysbiosis, with cohorts reporting rates as high as 66%.[20][21][20] Primary mechanisms include impaired motility and loss of the ileocecal valve.[7] Auto-brewery syndrome has been reported in several patients with short bowel syndrome.[22][23][24]
Intestinal Dysmotility
Intestinal dysmotility is one of the principal mechanisms leading to small intestinal microbial dysbiosis, as bowel stagnation allows microbial overgrowth and increases the contact time of food contents with microbes.[7] In addition to short bowel syndrome, several other forms of intestinal dysmotility have been reported as precipitants for auto-brewery syndrome. One case of auto-brewery syndrome reported chronic intestinal pseudo-obstruction, and another case reported on a patient with Crohn disease and a history of intestinal resection complicated by recurrent obstruction.[25][26] Since Roux-en-Y gastric bypass induces profound bacterial and fungal alterations, and since gastrointestinal surgery is a well-established risk factor for small intestinal microbial dysbiosis, certain gastrointestinal surgeries (particularly intestinal resections and creation of blind loops) may predispose to auto-brewery syndrome.[27][7]
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
MASLD has been closely associated with auto-brewery syndrome, but whether MASLD is a risk factor for auto-brewery syndrome or a consequence of endogenous ethanol over time remains unknown.[28] Bacterial production of endogenous ethanol is now understood as an important pathophysiologic contributor to MASLD, and contributes to disease progression to steatohepatitis and cirrhosis.[29][30][31][32][33][34]
Other Comorbidities
Chronic liver disease and diabetes mellitus have been associated with higher production of endogenous alcohol (particularly when both conditions are present), although not at levels high enough to cause intoxication.[35] However, auto-brewery syndrome has been reported in patients with diabetes mellitus and obesity, as well as in those with diabetes mellitus and cirrhosis.[36]
Genetics
A genetic polymorphism that reduces the activity of aldehyde dehydrogenase enzymes involved in the hepatic metabolism of ethanol might explain ethnic differences in rates of endogenous ethanol production and clearance.[37] However, the enzymes have not been specifically studied in patients with auto-brewery syndrome.
As with other forms of small intestinal microbial dysbiosis, auto-brewery syndrome is most common among patients with the above predisposing factors. In the proper anatomic or physiologic setting, disruption of the microbiota creates an opportunistic niche for alcohol-producing microorganisms to overgrow. Further downstream consequences hypothesized to contribute to symptoms include increased intestinal permeability and alterations in enteric neurotransmitters.[15][38]
Epidemiology
Auto-brewery syndrome is a rare condition, and epidemiologic data are largely limited to case reports and case series, so its population prevalence is unknown. Only recently has auto-brewery syndrome been studied in laboratories, but clinicians still face challenges in differentiating gut fermentation from exogenous sources. Auto-brewery syndrome has been reported in patients with various comorbidities, but is also being diagnosed in otherwise healthy individuals.[5][3]
The Auto Brewery Syndrome Advocacy nonprofit organization has identified over 300 patients diagnosed with auto-brewery syndrome by a licensed healthcare practitioner. According to information from the organization, the disease is identified mostly in male adults and very rarely in female adults and children, occurs in nearly 50 countries, and is likely underdiagnosed.[3]
Pathophysiology
In the normal human gut physiologic state, small amounts of endogenous ethanol are generated via microbial fermentation of dietary carbohydrates.[2][35][39] In healthy individuals, the amount of ethanol generated ranges from 0.01 to 0.3 mg/dL (mean 0.3 ± 0.41 mg/dL), which is insufficient to cause intoxication.[35] Moreover, the liver efficiently clears this minimal ethanol via first-pass metabolism.[13]
Auto-brewery syndrome is a type of small intestinal microbial dysbiosis, characterized by a perturbation of the endogenous microbiota toward pathologic levels of ethanol-generating bacteria and, more rarely, fungi/yeast.[1][40][1] This overabundance of ethanol-generating microbes causes excessive fermentation, leading to ethanol levels that exceed the liver's ability to metabolize them, resulting in signs and symptoms of ethanol intoxication.[1][2]
Historically, many auto-brewery syndrome cases have been attributed to fermenting yeasts, eg, Saccharomyces cerevisiae, S boulardii, and various Candida species, including C glabrata, C albicans, C kefyr, and C parapsilosis.[5] In most reported cases, information came from stool cultures before genomic sequencing became available. While many yeasts ferment alcohol, they have not been directly identified as contributing to auto-brewery syndrome using high-throughput sequencing.[1] The latest research reports that organisms implicated in auto-brewery syndrome are primarily from the Proteobacteria phylum (Pseudomonadata). The high-alcohol-producing bacteria include Klebsiella pneumoniae, Enterococcus faecium, E faecalis, E coli, and Citrobacter freundii.[1][29]
In patients with auto-brewery syndrome, distinct microbial profiles have also been identified. The microbiota in auto-brewery syndrome is enriched with Proteobacteria, especially Escherichia coli and Klebsiella pneumoniae.[1][15][29] Fecal samples from patients with auto-brewery syndrome generate detectable levels of alcohol in vitro, and antibiotics reduce this effect.[1] Bacterial production of endogenous ethanol is now recognized as an important pathophysiologic contributor to MASLD and contributes to disease progression to steatohepatitis and cirrhosis.[2][28][29][30]
The metabolome of patients with auto-brewery syndrome is also altered, favoring alcohol-producing pathways, with 133 pathways that differed from those of the household members.[1] Furthermore, 18 metabolic pathways were significantly different between periods when patients were producing alcohol (known as a flare) and when they were in remission.[1] Due to alcohol exposure over time, neurocircuitry is altered, and patients may experience alcohol cravings and develop alcohol use disorder.[3]
Auto-brewery syndrome has principally been attributed to perturbation of the gastrointestinal microbiome. However, 3 cases of extra-intestinal auto-brewery syndrome have been reported, 2 in the oral cavity and 1 in the urinary bladder.[40][41][42] The physiological changes due to oral and urinary auto-brewery syndrome have not yet been elucidated. A small number of patients relapse due to altered gastrointestinal physiology. Relapse has been reported after repeated antibiotic courses and after fecal microbiota transplantation (FMT).[1][43]
History and Physical
The signs and symptoms of auto-brewery syndrome derive from ethanol intoxication. In a systematic review of auto-brewery syndrome case reports, patients experienced slurred speech, fruity breath odor, gait disturbance, altered mood, seizures, vomiting, disorientation, and a general sense of intoxication.[5] In a cohort of 52 patients with auto-brewery syndrome, patients were significantly more likely than household controls to report bowel habit disturbances (particularly more frequent bowel movements), malodorous breath, and poorer overall health.[12]
Injuries and motor vehicle accidents have also been reported in patients with auto-brewery syndrome.[38][44] The amount of ethanol generated in auto-brewery syndrome varies widely, though some reports have documented very high levels, exceeding 300 mg/dL (0.30%). In these individuals, endogenous ethanol appears after the consumption of a high-carbohydrate diet. Stress and skipping meals may also exacerbate these high ethanol levels.[5]
A detailed history should be obtained to assess for gastrointestinal, endocrine, neurologic, and psychiatric causes for symptoms and to exclude alcohol use disorder. Detailed medical and surgical histories are required to identify risk factors and predisposing conditions. , as outlined in the Epidemiology section. Corroborating or conflicting information from family members can be helpful with the patient’s history. A detailed investigation into the patient's diet should be performed. Employing a dietary journal to track food, beverages, and breath alcohol levels is useful.[3]
Physical examination should include a detailed neurologic examination to rule out head injury or other neurological problems. Patients with auto-brewery syndrome need to be assessed for chronic liver disease from chronic hepatic exposure to ethanol.[45] The exam should include liver chemistry panels and scans for hepatic steatosis. Other sequelae of chronic ethanol exposure, eg, vitamin and micronutrient deficiencies, are possible, and patients may present as cachectic and depressed. Patients should be queried about alcohol withdrawal symptoms, especially when eating low-carbohydrate diets and abstaining from ingesting alcohol.[3]
Evaluation
No standardized diagnostic criteria currently exist for auto-brewery syndrome, and the proposed diagnostic framework is based primarily on case reports and expert opinion.
Because alcohol ingestion remains the most common cause of alcohol intoxication, clinicians should conduct a thorough assessment for alcohol use and alcohol use disorder in all patients undergoing evaluation. Ethanol biomarkers, including phosphatidylethanol (PEth) and ethyl glucuronide, may provide valuable qualitative and quantitative data to support the diagnostic process. For patients undergoing evaluation for auto-brewery syndrome, objective confirmation of endogenous ethanol production in the absence of exogenous alcohol exposure remains essential. The carbohydrate challenge test represents the preferred method for demonstrating endogenous ethanol generation and supporting the diagnosis.[6]
For this test, patients should be monitored to ensure they have no access to alcohol, in either an inpatient or outpatient setting. Patients should have their blood alcohol measured at baseline and then receive a standard 200 g glucose load, followed by an ad libitum high-carbohydrate diet. Blood alcohol concentrations (BAC) should be measured sequentially at 30 minutes, 1 hour, 2 hours, 4 hours, 8 hours, 16 hours, and 24 hours. The patient and observer should conduct and document breathalyzer readings hourly. BACs should also be ordered as needed in case the breathalyzer shows an elevation between stated BAC intervals.[3] Auto-brewery syndrome is confirmed if ethanol levels rise in response to the carbohydrate challenge.[6]
Some have also advocated for endoscopic sampling of intestinal fluid for bacterial and fungal cultures.[6] While this approach is important for identifying small intestinal microbial dysbiosis, it does not necessarily indicate auto-brewery syndrome and could lead to inappropriate use of antimicrobials. However, in conjunction with a carbohydrate challenge test, microbiological confirmation can help target therapy to the culprit organisms.
Similarly, some reports have utilized stool testing to identify potentially causative yeast and bacteria. However, simply identifying organisms does not indicate whether they are ethanol-generating and pathogenic. For example, Candida species are common gut commensals that, when cultured from stool, are implicated in auto-brewery syndrome. Moreover, there are many concerns about the reliability and applicability of stool-based microbiome testing.[46][47] Therefore, while stool-based tests and endoscopically obtained cultures can provide context, the sine qua non of auto-brewery syndrome is the endogenous formation of ethanol in response to dietary carbohydrates. Hence, the carbohydrate challenge is the single most important test.
Treatment / Management
Immediately upon the diagnosis of auto-brewery syndrome, patients should be monitored for alcohol toxicity and then withdrawal, and receive supportive measures as needed. Such support may range from hydration and vitamins to life-sustaining measures.[3] Once a patient is stabilized, the goal of treatment is to eradicate the overgrowth of fermenting organisms and correct the dysbiosis underlying auto-brewery syndrome.
No standardized treatments for auto-brewery syndrome have been established, so the treatment approach is largely empirical. However, diet and nutrition are essential components of any treatment, as they limit the substrates available to fermenting organisms and nourish beneficial bacteria that help keep fermenters in check.[14][48][49] For this reason, low-carbohydrate diets serve as the cornerstone of treatment for auto-brewery syndrome.
Patients should be directed to start a low-carbohydrate, alcohol-free diet and keep a log of all food and drink ingested and what their BAC registers on a breathalyzer. Consultation with a registered dietitian to tailor a nutritional plan is crucial. Continual BAC checks with a breathalyzer and patient-recorded data help assess treatment response and guide next steps.[3]
Since the fermentation is attributable to specific microbes, antimicrobials are the bedrock of therapy. In the absence of standardized diagnostic criteria, antimicrobial agents are often employed empirically, using broad-spectrum antibiotics that cover both aerobic and anaerobic enteric bacteria. Yuan and colleagues report that Klebsiella pneumoniae isolated from a patient with auto-brewery syndrome was highly susceptible to imipenem, and the patient responded well and recovered.[29] Xue and colleagues successfully treated a patient with auto-brewery syndrome with imipenem and demonstrated in rabbit and murine models that imipenem and levofloxacin reduced endogenous ethanol production.[15](B2)
Historically, cases of auto-brewery syndrome have been treated with antifungals, eg, azoles, polyenes, or echinocandins, but the data remain empirical. The use of antifungals, eg, fluconazole, should be judicious due to potential hepatotoxicity, especially in those with pre-existing liver disease. Ideally, microbiological data, eg, those from intestinal aspirate cultures, should inform the selection of an antimicrobial agent. Culture and sensitivity results from the suspected site of infection should also guide the choice of antimicrobial agents.[3][16][41] Importantly, while patients are undergoing antimicrobial therapy to eradicate the causative organisms, patients should be counseled to continue a low-carbohydrate, no alcohol diet.
Probiotics have been widely used in the literature to mitigate dysbiosis and shift the microbiota toward a more favorable state.[5] However, this approach is purely theoretical as its efficacy has not been rigorously evaluated.[49] In one case-control study describing auto-brewery syndrome attributed to high-ethanol-producing Klebsiella species, one patient was treated initially with levofloxacin (while following a low-carbohydrate diet), leading to resolution of symptoms; this was followed by treatment with a particular mix of probiotics selected to target specific abnormalities between the patient's microbiota and that of healthy controls. The regimen consisted of a twice-daily 26-strain Lactobacillus probiotic and a once daily Clostridium butyricum and Bacillus probiotic for 10 days, followed by 5 days of a Lactobacillus complex. By the end of treatment, the blood alcohol level had normalized, symptoms had improved, and fecal Klebsiella had significantly decreased.[15](A1)
An approach to microbiome restoration when other treatments fail is fecal microbiota transplantation (FMT). Emerging reports suggest a benefit of FMT in auto-brewery syndrome.[1][43][50] FMT has been shown to normalize ethanol levels, improve symptoms, and shift the microbiota composition toward that of healthy controls.[1] Multiple iterations of FMT may be required for adequate effect. In the reported cases, patients were eventually able to liberalize their diets without recurrence of auto-brewery syndrome.[1][43][50]
Importantly, because auto-brewery syndrome, like any form of small intestinal microbial dysbiosis, is a secondary condition, identifying underlying contributors and treating them accordingly is crucial to prevent relapses.[6] Even after reintroducing carbohydrates, it remains important to caution patients against excessive sugar and carbohydrate intake and to counsel them on healthy dietary practices to support a robust and resilient microbiome.[51] Additionally, in the absence of standardized treatment protocols, early intraprofessional involvement by members of the gastroenterology, infectious disease, nursing, and nutrition teams is key. (A1)
Differential Diagnosis
Differential Diagnoses
Other conditions that may have similar clinical features should be considered when evaluating patients with ethanol intoxication. To help exclude other differential diagnoses, before the medical appointment for testing, patients should be asked to purchase a breathalyzer and keep a daily logbook of food and drink, along with breathalyzer readings. This will help the patient become aware of any behaviors that may contribute to their symptoms and assist the clinician in developing a differential diagnosis.[3]
Covert alcohol use
Alcohol use disorder should be considered when assessing for auto-brewery syndrome. Not only are symptoms similar, but a person with auto-brewery syndrome may have alcohol use disorder as a comorbidity or may be at risk for developing alcohol use disorder as a result of the endogenous ethanol exposure over time. The breathalyzer and logbook will help with the assessment of covert alcohol use. Family members may also be asked to participate in the assessment of the patient’s alcohol use.
Unrecognized exposure to alcohol-containing products
Many foods contain alcohol in small amounts. For example, candy and other sweets may contain liqueurs or alcohol-derived extracts. Some mouthwashes also contain alcohol and can lead to a positive result on a breathalyzer; however, this effect is transient and not reflected in the blood due to a lack of systemic absorption.[3]
Other substances
The patient should be assessed for drug use, toxic alcohol ingestion (eg, methanol, ethylene glycol, isopropanol), occupational exposure toxicity, heavy metal poisoning, or toxic-metabolic encephalopathy. All prescription and over-the-counter medications should be assessed for medication adverse effects.
Comorbidities
The patient should be screened for hepatic encephalopathy and uremic encephalopathy. Seizure disorder, head trauma, chronic fatigue syndrome, and psychiatric disorders, including factitious disorder, should be ruled out. D-lactic acidosis should be part of the differential diagnosis, especially if the patient has short-bowel syndrome.[52]
Prognosis
Auto-brewery syndrome is a treatable condition, with eradication of the offending microbes and a temporary dietary carbohydrate restriction, followed by a moderately low-carbohydrate, no alcohol diet for life. Patients may have relapses due to dietary noncompliance. They may also have relapses if the culprit microbes were not eradicated or if underlying anatomic or physiologic predispositions are not addressed.[7]
Patients may also relapse if they use medications, especially antibiotics, that disrupt gut homeostasis. With successful treatment, patients can liberalize their diet somewhat, but should be aware of all factors that can disrupt the gut balance. A subset of patients has refractory disease even after FMT.[1] Better treatments and research are needed to determine if other underlying factors are present in patients who develop chronic auto-brewery syndrome.
Complications
Auto-brewery syndrome portends numerous medical and psychosocial complications. Due to the rarity of the condition and lack of standardized diagnostic protocols, patients often have marked delays in diagnosis. Since the vast majority of intoxication is due to alcohol ingestion, patients with auto-brewery syndrome are often suspected of having alcohol use disorder and face considerable stigma. Intoxication can predispose to injuries and even motor vehicle accidents.
Furthermore, affected individuals may be charged with driving while intoxicated and face legal consequences.[53] Medically, patients are at risk for all of the same complications that arise from chronic alcohol use. These include, but are not limited to, the development of chronic liver disease and cirrhosis, cardiovascular disease, vitamin and micronutrient deficiencies, peripheral neuropathy, dementia and Wernicke-Korsakoff syndrome, hematologic abnormalities, and cancer.
Alcohol withdrawal, including seizures, is also possible. Additionally, auto-brewery syndrome may even lead to alcohol use disorder. Alcohol use disorder may occur following successful treatment due to the neurochemical effects of chronic alcohol exposure.
Consultations
The treatment of auto-brewery syndrome should include an interprofessional team. These teams should include the primary care clinician, a consultation with gastroenterology and hepatology, and possibly infectious disease. Depending on the complications that a patient has developed, eg, addiction, consultations with neurology, psychiatry, and toxicology may be warranted.
Deterrence and Patient Education
Deterrence and patient education play central roles in reducing relapse and supporting long-term management of auto-brewery syndrome. Because dietary carbohydrates provide the substrate for endogenous ethanol production, patients receiving antimicrobial therapy should receive counseling to maintain a low-sugar, low-carbohydrate, alcohol-free diet throughout treatment. Referral to a licensed nutritionist supports individualized dietary planning and promotes nutritional adequacy while limiting conditions that favor microbial fermentation. Patients should also be instructed to monitor symptoms using a structured approach that includes routine breathalyzer measurements and maintenance of a detailed logbook documenting dietary intake, BACs, mood, and daily activities. These records can help identify triggers, assess treatment response, and guide ongoing therapeutic adjustments.
Education should extend beyond dietary modification and include comprehensive instruction regarding the pathophysiology of auto-brewery syndrome, relapse prevention strategies, and lifestyle factors that influence microbial balance. Referral to a nurse educator can reinforce self-management skills, improve adherence to treatment recommendations, and strengthen patient confidence in recognizing early signs of recurrence. Patients and family members should receive education regarding symptoms of alcohol withdrawal and the potential emergence of alcohol cravings, particularly following prolonged endogenous alcohol exposure. Future courses of antibiotics should prompt careful clinical monitoring because antibiotic-associated microbial disruption may precipitate relapse or recurrence. Referral for counseling or behavioral health support may also benefit patients experiencing trauma, depression, psychosocial distress, or other mental health concerns associated with the condition.
Pearls and Other Issues
Auto-brewery is a type of small intestinal microbial dysbiosis in which anatomic or physiologic predisposing factors, plus disruption of the gut microbiota, contribute to overgrowth of specific microbes that ferment dietary carbohydrates into ethanol, resulting in alcohol intoxication. While no standard diagnostic criteria have been established, patients should be assessed for covert alcohol use and should be documented for endogenous ethanol production via a monitored carbohydrate challenge.
Microbiological studies, particularly intestinal aspirate culture for bacteria and fungi, can help target therapy. The mainstay of therapy is antimicrobials to eradicate the culprit microbes. Whether or not using antimicrobials, a low-carbohydrate, alcohol-free diet is the cornerstone of treatment to reduce the substrates used by fermenting organisms. Probiotics and fecal microbiota transplantation are investigational therapies aimed at restoring the microbiota and preventing relapse. Sequelae of untreated auto-brewery syndrome include alcohol use disorder, MASLD, liver cirrhosis, and death.
Enhancing Healthcare Team Outcomes
Auto-brewery syndrome, or gut fermentation syndrome, is a rare and likely underdiagnosed disorder characterized by endogenous ethanol production via microbial fermentation, most commonly in the gastrointestinal tract and less frequently in the oral cavity or urinary tract. Pathophysiology involves microbial dysbiosis with overgrowth of ethanol-producing bacteria and, less commonly, fungi, leading to ethanol concentrations that exceed hepatic first-pass metabolism, resulting in symptoms of alcohol intoxication without alcohol ingestion. Predisposing factors include antibiotic exposure, high-carbohydrate diets, intestinal dysmotility, short bowel syndrome, metabolic dysfunction-associated steatotic liver disease, diabetes mellitus, altered gastrointestinal anatomy, and other disruptions of microbial homeostasis. Clinical manifestations range from episodic intoxication, altered mood, gait disturbance, and neurologic symptoms to chronic complications related to sustained alcohol exposure. Evaluation requires the exclusion of alcohol use and alternative etiologies, a comprehensive history and examination, and objective confirmation of endogenous ethanol production, with carbohydrate challenge testing as the key diagnostic approach. Management emphasizes stabilization, low-carbohydrate, alcohol-free dietary strategies, targeted antimicrobial therapy when appropriate, microbiome restoration in selected cases, and relapse prevention through treatment of underlying contributors.
Interprofessional collaboration improves diagnostic accuracy, reduces delays in recognition, and supports safer longitudinal management of auto-brewery syndrome. Physicians, primary care clinicians, and advanced practitioners coordinate diagnostic evaluation, interpret laboratory and clinical findings, identify predisposing conditions, and initiate evidence-informed treatment plans while facilitating timely referral to gastroenterology, infectious disease, hepatology, or behavioral health when indicated. Nurses reinforce patient education, monitor symptoms, assess for alcohol toxicity or withdrawal, promote adherence, and support longitudinal follow-up. Pharmacists evaluate medication-related contributors to dysbiosis, optimize antimicrobial selection, monitor adverse effects and drug interactions, and counsel on safe medication use. Registered dietitians develop individualized nutritional strategies and support dietary adherence. Shared decision-making, structured communication across care settings, patient-reported symptom and breath alcohol tracking, and coordinated follow-up reduce complications, improve quality of life, and strengthen systems-based care.
References
Hsu CL, Shukla S, Freund L, Chou AC, Yang Y, Bruellman R, Raya Tonetti F, Cabré N, Mayo S, Lim HG, Magallan V, Cordell BJ, Lang S, Demir M, Stärkel P, Llorente C, Palsson BO, Mandyam C, Boland BS, Hohmann E, Schnabl B. Gut microbial ethanol metabolism contributes to auto-brewery syndrome in an observational cohort. Nature microbiology. 2026 Feb:11(2):415-428. doi: 10.1038/s41564-025-02225-y. Epub 2026 Jan 8 [PubMed PMID: 41507585]
Meijnikman AS, Nieuwdorp M, Schnabl B. Endogenous ethanol production in health and disease. Nature reviews. Gastroenterology & hepatology. 2024 Aug:21(8):556-571. doi: 10.1038/s41575-024-00937-w. Epub 2024 Jun 3 [PubMed PMID: 38831008]
Cordell B. Auto-Brewery Syndrome: Diagnosis and Treatment of This Little-Known Condition. The American journal of nursing. 2025 Aug 1:125(8):30-37. doi: 10.1097/AJN.0000000000000116. Epub 2025 Jul 24 [PubMed PMID: 40702625]
Zewude RT, Croitoru K, Das R, Goldman B, Bogoch II. Auto-brewery syndrome in a 50-year-old woman. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2024 Jun 2:196(21):E724-E727. doi: 10.1503/cmaj.231319. Epub 2024 Jun 2 [PubMed PMID: 38830676]
Bayoumy AB, Mulder CJJ, Mol JJ, Tushuizen ME. Gut fermentation syndrome: A systematic review of case reports. United European gastroenterology journal. 2021 Apr:9(3):332-342. doi: 10.1002/ueg2.12062. Epub 2021 Apr 22 [PubMed PMID: 33887125]
Level 3 (low-level) evidenceMalik F, Wickremesinghe P, Saverimuttu J. Case report and literature review of auto-brewery syndrome: probably an underdiagnosed medical condition. BMJ open gastroenterology. 2019:6(1):e000325. doi: 10.1136/bmjgast-2019-000325. Epub 2019 Aug 5 [PubMed PMID: 31423320]
Level 3 (low-level) evidenceDamianos JA, Wang XJ, Camilleri M. Mechanisms and pathophysiology leading to development of small intestinal microbial dysbiosis. The lancet. Gastroenterology & hepatology. 2026 Mar:11(3):256-266. doi: 10.1016/S2468-1253(25)00295-X. Epub 2026 Jan 14 [PubMed PMID: 41547360]
Baldanzi G, Larsson A, Sayols-Baixeras S, Dekkers KF, Hammar U, Nguyen D, Graells T, Ahmad S, Gazolla Volpiano C, Meric G, Järhult JD, Tängdén T, Ludvigsson JF, Lind L, Sundström J, Michaëlsson K, Ärnlöv J, Kennedy B, Orho-Melander M, Fall T. Antibiotic use and gut microbiome composition links from individual-level prescription data of 14,979 individuals. Nature medicine. 2026 Apr:32(4):1351-1361. doi: 10.1038/s41591-026-04284-y. Epub 2026 Mar 11 [PubMed PMID: 41814006]
Iizumi T, Battaglia T, Ruiz V, Perez Perez GI. Gut Microbiome and Antibiotics. Archives of medical research. 2017 Nov:48(8):727-734. doi: 10.1016/j.arcmed.2017.11.004. Epub 2017 Dec 6 [PubMed PMID: 29221800]
Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, Brochado AR, Fernandez KC, Dose H, Mori H, Patil KR, Bork P, Typas A. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature. 2018 Mar 29:555(7698):623-628. doi: 10.1038/nature25979. Epub 2018 Mar 19 [PubMed PMID: 29555994]
Bode JC, Rust S, Bode C. The effect of cimetidine treatment on ethanol formation in the human stomach. Scandinavian journal of gastroenterology. 1984 Sep:19(6):853-6 [PubMed PMID: 6515321]
Cordell BJ, Kanodia A, Miller GK. Case-Control Research Study of Auto-Brewery Syndrome. Global advances in health and medicine. 2019:8():2164956119837566. doi: 10.1177/2164956119837566. Epub 2019 Apr 18 [PubMed PMID: 31037230]
Level 2 (mid-level) evidenceMeijnikman AS, Davids M, Herrema H, Aydin O, Tremaroli V, Rios-Morales M, Levels H, Bruin S, de Brauw M, Verheij J, Kemper M, Holleboom AG, Tushuizen ME, Schwartz TW, Nielsen J, Brandjes D, Dirinck E, Weyler J, Verrijken A, De Block CEM, Vonghia L, Francque S, Beuers U, Gerdes VEA, Bäckhed F, Groen AK, Nieuwdorp M. Microbiome-derived ethanol in nonalcoholic fatty liver disease. Nature medicine. 2022 Oct:28(10):2100-2106. doi: 10.1038/s41591-022-02016-6. Epub 2022 Oct 10 [PubMed PMID: 36216942]
Elshaghabee FM, Bockelmann W, Meske D, de Vrese M, Walte HG, Schrezenmeir J, Heller KJ. Ethanol Production by Selected Intestinal Microorganisms and Lactic Acid Bacteria Growing under Different Nutritional Conditions. Frontiers in microbiology. 2016:7():47. doi: 10.3389/fmicb.2016.00047. Epub 2016 Jan 29 [PubMed PMID: 26858714]
Xue G, Feng J, Zhang R, Du B, Sun Y, Liu S, Yan C, Liu X, Du S, Feng Y, Cui J, Gan L, Zhao H, Fan Z, Cui X, Xu Z, Fu T, Li C, Huang L, Zhang T, Wang J, Yang R, Yuan J. Three Klebsiella species as potential pathobionts generating endogenous ethanol in a clinical cohort of patients with auto-brewery syndrome: a case control study. EBioMedicine. 2023 May:91():104560. doi: 10.1016/j.ebiom.2023.104560. Epub 2023 Apr 13 [PubMed PMID: 37060744]
Level 2 (mid-level) evidenceFarkašová Iannaccone S, Ginelliová A, Briškárová V, Farkaš D. Auto-brewery syndrome with Candida-associated gastric ulcers in a severely cachectic child. Forensic science, medicine, and pathology. 2026 Jan 12:():. doi: 10.1007/s12024-025-01170-w. Epub 2026 Jan 12 [PubMed PMID: 41525019]
Koutromanos I, Legaki E, Gazouli M, Vasilopoulos E, Kouzoupis A, Tzavellas E. Gut microbiome in alcohol use disorder: Implications for health outcomes and therapeutic strategies-a literature review. World journal of methodology. 2024 Mar 20:14(1):88519. doi: 10.5662/wjm.v14.i1.88519. Epub 2024 Mar 20 [PubMed PMID: 38577203]
Pich EM, Tarnanas I, Brigidi P, Collo G. Gut Microbiome-Liver-Brain axis in Alcohol Use Disorder. The role of gut dysbiosis and stress in alcohol-related cognitive impairment progression: possible therapeutic approaches. Neurobiology of stress. 2025 Mar:35():100713. doi: 10.1016/j.ynstr.2025.100713. Epub 2025 Feb 8 [PubMed PMID: 40092632]
Andres-Hernando A, Orlicky DJ, Garcia GE, Loetz EC, Montoya R, Kumar V, Effinger DP, Kuwabara M, Bae SY, Lorenzo-Rebenaque L, Fauste E, Bell RL, Grahame N, Liangpunsakul S, Kim H, Dugar S, Maffuid P, Nakagawa T, Wempe MF, Petrash JM, Tolan DR, Bland ST, Johnson RJ, Lanaspa MA. Identification of a common ketohexokinase-dependent link driving alcohol intake and alcohol-associated liver disease in mice. Nature metabolism. 2025 Nov:7(11):2250-2267. doi: 10.1038/s42255-025-01402-x. Epub 2025 Nov 10 [PubMed PMID: 41214144]
Dibaise JK, Young RJ, Vanderhoof JA. Enteric microbial flora, bacterial overgrowth, and short-bowel syndrome. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2006 Jan:4(1):11-20 [PubMed PMID: 16431299]
Hilberath J, Busch A, Schoppmeier U, Schmauder K, Oberhettinger P, Marschal M, Slavetinsky C, Sturm E, Peter S, D'Alvise P. Small intestinal bacterial overgrowth and dysbiosis in children with intestinal failure: A descriptive cohort study. JPEN. Journal of parenteral and enteral nutrition. 2025 Nov:49(8):964-974. doi: 10.1002/jpen.2808. Epub 2025 Jul 28 [PubMed PMID: 40722249]
Green AD, Antonson DL, Simonsen KA. Twelve-year-old female with short bowel syndrome presents with dizziness and confusion. The Pediatric infectious disease journal. 2012 Apr:31(4):425. doi: 10.1097/INF.0b013e318241590f. Epub [PubMed PMID: 22418655]
Level 3 (low-level) evidenceJansson-Nettelbladt E, Meurling S, Petrini B, Sjölin J. Endogenous ethanol fermentation in a child with short bowel syndrome. Acta paediatrica (Oslo, Norway : 1992). 2006 Apr:95(4):502-4 [PubMed PMID: 16720504]
Level 3 (low-level) evidenceDahshan A, Donovan K. Auto-brewery syndrome in a child with short gut syndrome: case report and review of the literature. Journal of pediatric gastroenterology and nutrition. 2001 Aug:33(2):214-5 [PubMed PMID: 11568528]
Level 3 (low-level) evidenceSpinucci G, Guidetti M, Lanzoni E, Pironi L. Endogenous ethanol production in a patient with chronic intestinal pseudo-obstruction and small intestinal bacterial overgrowth. European journal of gastroenterology & hepatology. 2006 Jul:18(7):799-802 [PubMed PMID: 16772842]
Level 3 (low-level) evidenceWelch BT, Coelho Prabhu N, Walkoff L, Trenkner SW. Auto-brewery Syndrome in the Setting of Long-standing Crohn's Disease: A Case Report and Review of the Literature. Journal of Crohn's & colitis. 2016 Dec:10(12):1448-1450 [PubMed PMID: 27161390]
Level 3 (low-level) evidenceSteinert RE, Rehman A, Souto Lima EJ, Agamennone V, Schuren FHJ, Gero D, Schreiner P, Vonlanthen R, Ismaeil A, Tzafos S, Hosa H, Vetter D, Misselwitz B, Bueter M. Roux-en-Y gastric bypass surgery changes fungal and bacterial microbiota in morbidly obese patients-A pilot study. PloS one. 2020:15(7):e0236936. doi: 10.1371/journal.pone.0236936. Epub 2020 Jul 31 [PubMed PMID: 32735609]
Level 3 (low-level) evidenceAndaloro S, De Gaetano V, Cardone F, Ianiro G, Cerrito L, Pallozzi M, Stella L, Gasbarrini A, Ponziani FR. Autobrewery Syndrome and Endogenous Ethanol Production in Patients with MASLD: A Perspective from Chronic Liver Disease. International journal of molecular sciences. 2025 Jul 30:26(15):. doi: 10.3390/ijms26157345. Epub 2025 Jul 30 [PubMed PMID: 40806476]
Level 3 (low-level) evidenceYuan J, Chen C, Cui J, Lu J, Yan C, Wei X, Zhao X, Li N, Li S, Xue G, Cheng W, Li B, Li H, Lin W, Tian C, Zhao J, Han J, An D, Zhang Q, Wei H, Zheng M, Ma X, Li W, Chen X, Zhang Z, Zeng H, Ying S, Wu J, Yang R, Liu D. Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae. Cell metabolism. 2019 Dec 3:30(6):1172. doi: 10.1016/j.cmet.2019.11.006. Epub [PubMed PMID: 31801057]
Aragonès G, González-García S, Aguilar C, Richart C, Auguet T. Gut Microbiota-Derived Mediators as Potential Markers in Nonalcoholic Fatty Liver Disease. BioMed research international. 2019:2019():8507583. doi: 10.1155/2019/8507583. Epub 2019 Jan 2 [PubMed PMID: 30719448]
Li NN, Li W, Feng JX, Zhang WW, Zhang R, Du SH, Liu SY, Xue GH, Yan C, Cui JH, Zhao HQ, Feng YL, Gan L, Zhang Q, Chen C, Liu D, Yuan J. High alcohol-producing Klebsiella pneumoniae causes fatty liver disease through 2,3-butanediol fermentation pathway in vivo. Gut microbes. 2021 Jan-Dec:13(1):1979883. doi: 10.1080/19490976.2021.1979883. Epub [PubMed PMID: 34632939]
Nair S, Cope K, Risby TH, Diehl AM. Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis. The American journal of gastroenterology. 2001 Apr:96(4):1200-4 [PubMed PMID: 11316170]
Baker SS, Baker RD, Liu W, Nowak NJ, Zhu L. Role of alcohol metabolism in non-alcoholic steatohepatitis. PloS one. 2010 Mar 8:5(3):e9570. doi: 10.1371/journal.pone.0009570. Epub 2010 Mar 8 [PubMed PMID: 20221393]
Zhu L, Baker RD, Zhu R, Baker SS. Gut microbiota produce alcohol and contribute to NAFLD. Gut. 2016 Jul:65(7):1232. doi: 10.1136/gutjnl-2016-311571. Epub 2016 Mar 16 [PubMed PMID: 26984853]
Hafez EM, Hamad MA, Fouad M, Abdel-Lateff A. Auto-brewery syndrome: Ethanol pseudo-toxicity in diabetic and hepatic patients. Human & experimental toxicology. 2017 May:36(5):445-450. doi: 10.1177/0960327116661400. Epub 2016 Aug 4 [PubMed PMID: 27492480]
Patel P, Patel D, Gutlapalli SD, Okorie IJ, Onana AE, Ugwendum D, Arrey Agbor DB, Munoh Kenne F, Otterbeck P, Nfonoyim J. The Associations of Auto-Brewery Syndrome and Diabetes Mellitus: A Literature Review and Clinical Perspective. Cureus. 2023 Jul:15(7):e41924. doi: 10.7759/cureus.41924. Epub 2023 Jul 15 [PubMed PMID: 37588335]
Level 3 (low-level) evidenceUshida Y, Talalay P. Sulforaphane accelerates acetaldehyde metabolism by inducing aldehyde dehydrogenases: relevance to ethanol intolerance. Alcohol and alcoholism (Oxford, Oxfordshire). 2013 Sep-Oct:48(5):526-34. doi: 10.1093/alcalc/agt063. Epub 2013 Jul 3 [PubMed PMID: 23825090]
Level 3 (low-level) evidenceDinis-Oliveira RJ. The Auto-Brewery Syndrome: A Perfect Metabolic "Storm" with Clinical and Forensic Implications. Journal of clinical medicine. 2021 Oct 10:10(20):. doi: 10.3390/jcm10204637. Epub 2021 Oct 10 [PubMed PMID: 34682761]
Miller TL, Wolin MJ. Fermentations by saccharolytic intestinal bacteria. The American journal of clinical nutrition. 1979 Jan:32(1):164-72 [PubMed PMID: 760499]
Takahashi G, Hoshikawa K, Kan S, Akimaru R, Kodama Y, Sato T, Kakisaka K, Yamada Y. Auto-brewery syndrome caused by oral fungi and periodontal disease bacteria. Acute medicine & surgery. 2021 Jan-Dec:8(1):e652. doi: 10.1002/ams2.652. Epub 2021 May 3 [PubMed PMID: 33976897]
Smędra A, Trzmielak M, Góralska K, Dzikowiec M, Brzeziańska-Lasota E, Berent J. Oral form of auto-brewery syndrome. Journal of forensic and legal medicine. 2022 Apr:87():102333. doi: 10.1016/j.jflm.2022.102333. Epub 2022 Mar 9 [PubMed PMID: 35290834]
Kruckenberg KM, DiMartini AF, Rymer JA, Pasculle AW, Tamama K. Urinary Auto-brewery Syndrome: A Case Report. Annals of internal medicine. 2020 May 19:172(10):702-704. doi: 10.7326/L19-0661. Epub 2020 Feb 25 [PubMed PMID: 32092761]
Level 3 (low-level) evidenceCasañas-Martínez M, Barbero-Herranz R, Alegre-González D, Mosquera-Lozano JD, Del Campo R, Metagenomic Study Group. Fecal microbiota transplantation in a long-standing auto-brewery syndrome with complex symptomatology. Journal of hepatology. 2025 Apr:82(4):e186-e188. doi: 10.1016/j.jhep.2024.12.005. Epub 2024 Dec 6 [PubMed PMID: 39647535]
Simic M, Ajdukovic N, Veselinovic I, Mitrovic M, Djurendic-Brenesel M. Endogenous ethanol production in patients with diabetes mellitus as a medicolegal problem. Forensic science international. 2012 Mar 10:216(1-3):97-100. doi: 10.1016/j.forsciint.2011.09.003. Epub 2011 Sep 25 [PubMed PMID: 21945304]
Level 2 (mid-level) evidenceParamsothy J, Gutlapalli SD, Ganipineni VDP, Okorie IJ, Ugwendum D, Piccione G, Ducey J, Kouyate G, Onana A, Emmer L, Arulthasan V, Otterbeck P, Nfonoyim J. Understanding Auto-Brewery Syndrome in 2023: A Clinical and Comprehensive Review of a Rare Medical Condition. Cureus. 2023 Apr:15(4):e37678. doi: 10.7759/cureus.37678. Epub 2023 Apr 17 [PubMed PMID: 37206535]
Level 3 (low-level) evidencePorcari S, Mullish BH, Asnicar F, Ng SC, Zhao L, Hansen R, O'Toole PW, Raes J, Hold G, Putignani L, Hvas CL, Zeller G, Koren O, Tun H, Valles-Colomer M, Collado MC, Fischer M, Allegretti J, Iqbal T, Chassaing B, Keller J, Baunwall SM, Abreu M, Barbara G, Zhang F, Ponziani FR, Costello SP, Paramsothy S, Kao D, Kelly C, Kupcinskas J, Youngster I, Franceschi F, Khanna S, Vehreschild M, Link A, De Maio F, Pasolli E, Miguez AB, Brigidi P, Posteraro B, Scaldaferri F, Stojanovic MR, Megraud F, Malfertheiner P, Masucci L, Arumugam M, Kaakoush N, Segal E, Bajaj J, Leong R, Cryan J, Weersma RK, Knight R, Guarner F, Shanahan F, Cani PD, Elinav E, Sanguinetti M, de Vos WM, El-Omar E, Dorè J, Marchesi J, Tilg H, Sokol H, Segata N, Cammarota G, Gasbarrini A, Ianiro G. International consensus statement on microbiome testing in clinical practice. The lancet. Gastroenterology & hepatology. 2025 Feb:10(2):154-167. doi: 10.1016/S2468-1253(24)00311-X. Epub 2024 Dec 5 [PubMed PMID: 39647502]
Level 3 (low-level) evidenceServetas SL, Gierz KS, Hoffmann D, Ravel J, Jackson SA. Evaluating the analytical performance of direct-to-consumer gut microbiome testing services. Communications biology. 2026 Feb 26:9(1):. doi: 10.1038/s42003-025-09301-3. Epub 2026 Feb 26 [PubMed PMID: 41748906]
Peters AR. Use of a long-acting oxytetracycline preparation in respiratory disease in young beef bulls. The Veterinary record. 1985 Mar 23:116(12):321 [PubMed PMID: 3992845]
Damianos JA. Response to Endogenous Ethanol Production in the Human Alimentary Tract: A Literature Review. Journal of gastroenterology and hepatology. 2025 May:40(5):1317-1318. doi: 10.1111/jgh.16924. Epub 2025 Feb 28 [PubMed PMID: 40017434]
Vandekerckhove E, Janssens F, Tate D, De Looze D. Treatment of Gut Fermentation Syndrome With Fecal Microbiota Transplantation. Annals of internal medicine. 2020 Nov 17:173(10):855. doi: 10.7326/L20-0341. Epub 2020 Aug 18 [PubMed PMID: 32805128]
Hughes RL, Alvarado DA, Swanson KS, Holscher HD. The Prebiotic Potential of Inulin-Type Fructans: A Systematic Review. Advances in nutrition (Bethesda, Md.). 2022 Mar:13(2):492-529. doi: 10.1093/advances/nmab119. Epub 2023 Feb 10 [PubMed PMID: 34555168]
Level 1 (high-level) evidenceKowlgi NG, Chhabra L. D-lactic acidosis: an underrecognized complication of short bowel syndrome. Gastroenterology research and practice. 2015:2015():476215. doi: 10.1155/2015/476215. Epub 2015 Apr 22 [PubMed PMID: 25977687]
Akbaba M. A medicolegal approach to the very rare Auto-Brewery (endogenous alcohol fermentation) syndrome. Traffic injury prevention. 2020:21(5):295-297. doi: 10.1080/15389588.2020.1740688. Epub 2020 Apr 7 [PubMed PMID: 32255712]